chr12-2582938-A-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_000719.7(CACNA1C):​c.2220A>G​(p.Gly740Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000958 in 1,566,002 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.000013 ( 0 hom., cov: 32)
Exomes š‘“: 0.0000092 ( 0 hom. )

Consequence

CACNA1C
NM_000719.7 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.99

Publications

0 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 12-2582938-A-G is Benign according to our data. Variant chr12-2582938-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 456952.
BS2
High AC in GnomAdExome4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 ENST00000399655.6 NP_000710.5
CACNA1CNM_001167623.2 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 ENST00000399603.6 NP_001161095.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 5 NM_001167623.2 ENSP00000382512.1
CACNA1CENST00000399655.6 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 NM_000719.7 ENSP00000382563.1
CACNA1CENST00000682544.1 linkc.2310A>G p.Gly770Gly synonymous_variant Exon 15 of 50 ENSP00000507184.1
CACNA1CENST00000406454.8 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 48 5 ENSP00000385896.3
CACNA1CENST00000399634.6 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 5 ENSP00000382542.2
CACNA1CENST00000683824.1 linkc.2385A>G p.Gly795Gly synonymous_variant Exon 16 of 48 ENSP00000507867.1
CACNA1CENST00000347598.9 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 49 1 ENSP00000266376.6
CACNA1CENST00000344100.7 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000341092.3
CACNA1CENST00000327702.12 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 48 1 ENSP00000329877.7
CACNA1CENST00000399617.6 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 48 5 ENSP00000382526.1
CACNA1CENST00000682462.1 linkc.2310A>G p.Gly770Gly synonymous_variant Exon 15 of 47 ENSP00000507105.1
CACNA1CENST00000683781.1 linkc.2310A>G p.Gly770Gly synonymous_variant Exon 15 of 47 ENSP00000507434.1
CACNA1CENST00000683840.1 linkc.2310A>G p.Gly770Gly synonymous_variant Exon 15 of 47 ENSP00000507612.1
CACNA1CENST00000683956.1 linkc.2310A>G p.Gly770Gly synonymous_variant Exon 15 of 47 ENSP00000506882.1
CACNA1CENST00000399638.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 48 1 ENSP00000382547.1
CACNA1CENST00000335762.10 linkc.2295A>G p.Gly765Gly synonymous_variant Exon 16 of 48 5 ENSP00000336982.5
CACNA1CENST00000399606.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 48 1 ENSP00000382515.1
CACNA1CENST00000399621.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382530.1
CACNA1CENST00000399637.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382546.1
CACNA1CENST00000402845.7 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000385724.3
CACNA1CENST00000399629.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382537.1
CACNA1CENST00000682336.1 linkc.2295A>G p.Gly765Gly synonymous_variant Exon 16 of 47 ENSP00000507898.1
CACNA1CENST00000399591.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 46 1 ENSP00000382500.1
CACNA1CENST00000399595.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 46 1 ENSP00000382504.1
CACNA1CENST00000399649.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 46 1 ENSP00000382557.1
CACNA1CENST00000399597.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382506.1
CACNA1CENST00000399601.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382510.1
CACNA1CENST00000399641.6 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382549.1
CACNA1CENST00000399644.5 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 1 ENSP00000382552.1
CACNA1CENST00000682835.1 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 47 ENSP00000507282.1
CACNA1CENST00000683482.1 linkc.2211A>G p.Gly737Gly synonymous_variant Exon 15 of 47 ENSP00000507169.1
CACNA1CENST00000682686.1 linkc.2220A>G p.Gly740Gly synonymous_variant Exon 15 of 46 ENSP00000507309.1
CACNA1CENST00000480911.6 linkn.*827A>G non_coding_transcript_exon_variant Exon 13 of 27 5 ENSP00000437936.2
CACNA1CENST00000480911.6 linkn.*827A>G 3_prime_UTR_variant Exon 13 of 27 5 ENSP00000437936.2

Frequencies

GnomAD3 genomes
AF:
0.0000131
AC:
2
AN:
152142
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
173054
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000919
AC:
13
AN:
1413860
Hom.:
0
Cov.:
30
AF XY:
0.0000100
AC XY:
7
AN XY:
698720
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32354
American (AMR)
AF:
0.00
AC:
0
AN:
37448
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25380
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37448
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80226
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
50482
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5386
European-Non Finnish (NFE)
AF:
0.0000120
AC:
13
AN:
1086532
Other (OTH)
AF:
0.00
AC:
0
AN:
58604
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000131
AC:
2
AN:
152142
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74310
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41406
American (AMR)
AF:
0.00
AC:
0
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000294
AC:
2
AN:
68024
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000329
Hom.:
0
Bravo
AF:
0.0000264

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cardiovascular phenotype Uncertain:1
Nov 21, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2220A>G variant (also known as p.G740G), located in coding exon 15 of the CACNA1C gene, results from an A to G substitution at nucleotide position 2220. This nucleotide substitution does not change the glycine at codon 740. This nucleotide position is well conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may weaken the native splice donor site. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

CACNA1C-related disorder Benign:1
May 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Long QT syndrome Benign:1
Nov 30, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.58
CADD
Benign
8.5
DANN
Benign
0.78
PhyloP100
2.0

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.30
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.30
Position offset: 4

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs940854113; hg19: chr12-2692104; API